Locations:

Tag: statin intolerance

LDL cholesterol particle with male and female symbols atop it

April 29, 2024/Heart, Vascular and Thoracic/Preventive Cardiology

CLEAR Outcomes Subanalysis Shows Bempedoic Acid’s Clinical Benefits Apply Equally to Women and Men

Reassurance from the lipid outcomes trial with the highest percentage female enrollment to date

23-HVI-3606660_LDL-cholesterol-particles_650x450

March 4, 2023/Heart, Vascular and Thoracic/Preventive Cardiology

CLEAR Outcomes: Bempedoic Acid Reduces Cardiovascular Events in Statin-Intolerant Patients

Findings bolster the oral drug as an option for primary and secondary prevention

21-HVI-2500365_LDL-cholesterol-particles_650x450

October 26, 2021/Heart, Vascular and Thoracic/Preventive Cardiology

Statin Intolerance and New Lipid-Lowering Treatments

Updated guidance on identification and strategies for management

January 9, 2020/Heart, Vascular and Thoracic/News & Insights

Two Reasons Why LDL Cholesterol Management Isn’t as Settled as You May Think

Intermittent statin dosing & bempedoic acid refresh the mix of options

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

November 14, 2019/Leadership/Leadership Highlights

No. 8 Medical Innovation for 2020: Bempedoic Acid for Statin-Intolerant Patients

Reduces muscle pain caused by cholesterol-lowering drugs

March 18, 2019/Heart, Vascular and Thoracic/Insight & Perspectives

Statin Intolerance: Pearls for Practice in the PCSK9 Inhibitor Era

Q&A with the director of our dedicated program for statin intolerance

BackPage 1 of 1Next